Stem Cell Prognosticators in Myelodysplastic Syndromes

Pallavicini, Maria G.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01CA060417-03
• Application #: 2101154
• Study Section: Special Emphasis Panel (SRC (51))
• Project Start: 1993-09-30
• Project End: 1997-09-29
• Budget Start: 1995-09-30
• Budget End: 1997-09-29
• Support Year: 3
• Fiscal Year: 1995

Institution

• Name: University of California San Francisco
• Department: Pathology
• Type: Schools of Medicine
• DUNS #: 073133571
• City: San Francisco
• State: CA
• Country: United States
• Zip Code: 94143

Publications

Quijano, C A; Moore 2nd, D; Arthur, D et al. (1997) Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia. Leukemia 11:1508-15

Miles, D K; Freedman, M H; Stephens, K et al. (1996) Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Blood 88:4314-20

Mehrotra, B; George, T I; Kavanau, K et al. (1995) Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Blood 86:1139-47